4//SEC Filing
Finegan Michael 4
Accession 0001209191-20-035294
CIK 0000884624other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:54 PM ET
Size
9.0 KB
Accession
0001209191-20-035294
Insider Transaction Report
Form 4
Finegan Michael
VP-Bus.Dev&President-Biologics
Transactions
- Exercise/Conversion
Common Stock
2020-06-05$21.78/sh+8,750$190,575→ 56,683 total - Sale
Common Stock
2020-06-05$37.41/sh−8,750$327,323→ 47,933 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-05−8,750→ 0 totalExercise: $21.78Exp: 2023-09-26→ Common Stock (8,750 underlying)
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.22 to $37.76, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, September 26, 2013.
Documents
Issuer
Orthofix Medical Inc.
CIK 0000884624
Entity typeother
Related Parties
1- filerCIK 0001391402
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:54 PM ET
- Size
- 9.0 KB